Seelos Therapeutics   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: New York NY United States (2016)

Organization Overview

First Clinical Trial
2020
NCT04669665
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Seelos Therapeutics, Inc.